Shimagami, Hiroshi
Nishimura, Kei
Matsushita, Hiroaki
Metsugi, Shoichi
Kato, Yasuhiro https://orcid.org/0000-0002-4050-2350
Kawasaki, Takahiro
Tsujimoto, Kohei
Edahiro, Ryuya
Itotagawa, Eri
Naito, Maiko https://orcid.org/0000-0002-4360-7043
Kawada, Shoji
Nakatsubo, Daisuke https://orcid.org/0009-0004-0517-0874
Matsukawa, Kazuki
Namba-Hamano, Tomoko https://orcid.org/0000-0002-6049-7616
Inoue, Kazunori https://orcid.org/0000-0002-7149-6651
Takahashi, Atsushi
Mizui, Masayuki https://orcid.org/0000-0003-2543-8108
Kato, Seiya https://orcid.org/0009-0005-9116-9729
Hikita, Hayato https://orcid.org/0000-0003-2488-7315
Nakazawa, Shigeaki
Kakuta, Yoichi https://orcid.org/0000-0001-5339-4312
Konaka, Hachiro
Mitsumoto, Kensuke
Ishikawa, Nachi
Fujimoto, Jun
Higa, Shinji
Omiya, Ryusuke
Isaka, Yoshitaka https://orcid.org/0000-0002-0820-7167
Takehara, Tetsuo https://orcid.org/0000-0001-5036-3457
Nonomura, Norio
Okada, Yukinori https://orcid.org/0000-0002-0311-8472
Hattori, Kunihiro
Narazaki, Masashi
Kumanogoh, Atsushi https://orcid.org/0000-0003-4749-7117
Nishide, Masayuki https://orcid.org/0000-0001-6060-1228
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP24K11596)
MEXT | Japan Science and Technology Agency (JPMJFR235B)
Article History
Received: 12 July 2024
Accepted: 9 May 2025
First Online: 17 June 2025
Competing interests
: A.K. has received grant support from Chugai Pharmaceutical Co, Ltd. K.N., H.M., S.M., R.O., K.H. are employed by Chugai Pharmaceutical Co, Ltd. and K.N., H.M., S.M., R.O., K.H. also hold stocks in the company. The remaining authors declare no competing interests.